Numab
company
About
Numab is a biotechnology company that offers antibody-based therapeutics for the treatment of severe diseases.
- 51 - 100
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- Fr22M
- Industries
- Biopharma,Biotechnology,Health Care,Health Diagnostics,Life Science,Medical,Therapeutics
- Founded date
- Jan 1, 2011
- Number Of Employee
- 51 - 100
- Operating Status
- Active
Numab is a biotechnology company that offers antibody-based therapeutics for the treatment of severe diseases such as chronic inflammation and cancer. It features a plug-and-play platform that substantially reduces the random nature of the discovery process to predictably yield ready-to-develop multispecific biotherapeutics.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
Fr22M
Numab has raised a total of
Fr22M
in funding over 2 rounds. Their latest funding was raised on
Dec 12, 2019 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Dec 12, 2019 | Series B | Fr22M | 1 | — | — | Detail |
Investments
Number of Investments
Number of Lead Investments
1
1
Numab has made 1 investments. Their most recent investment was on
Dec 12, 2019, when 3sbio raised Fr15M.
|
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|
|
Dec 12, 2019
3sbio
|
Post-IPO Equity | Fr15M | Biotechnology | Yes |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
